-
1
-
-
0023820360
-
The Christie Hospital adjuvant tamoxifen trial-status at 10 years
-
Riberio, G., and Swindell, R. The Christie Hospital adjuvant tamoxifen trial-status at 10 years. Br. J. Cancer, 57:601-603,1988.
-
(1988)
Br. J. Cancer
, vol.57
, pp. 601-603
-
-
Riberio, G.1
Swindell, R.2
-
2
-
-
0021918182
-
Controlled trial of tamoxifen as single adjuvant agent in the management of early breast cancer analysis at six years by Nolvadex Adjuvant Trial Organization
-
Baum, M. Controlled trial of tamoxifen as single adjuvant agent in the management of early breast cancer analysis at six years by Nolvadex Adjuvant Trial Organization. Cancer (Phila.), 1:836-839,198S.
-
Cancer (Phila.)
, vol.1
, pp. 836-839
-
-
Baum, M.1
-
3
-
-
84970073053
-
Anonymous. ODAC endorses tamoxifen trial, with modification to ensure enrollment of women at higher risk
-
Anonymous. ODAC endorses tamoxifen trial, with modification to ensure enrollment of women at higher risk. Cancer Lett., 17 (No. 31); 1-3,1991.
-
(1991)
Cancer Lett.
, vol.17
, Issue.31
, pp. 1-3
-
-
-
4
-
-
0020003085
-
Tamoxifen and metabolites in MCF-cells: correlation between binding to estrogen receptor and inhibition of cell growth
-
Coezy, E., Borgna, J-L., and Rochefort, H. Tamoxifen and metabolites in MCF-cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res., 42:317-323, 1982.
-
(1982)
Cancer Res.
, vol.42
, pp. 317-323
-
-
Coezy, E.1
Borgna, J.-L.2
Rochefort, H.3
-
5
-
-
0023229345
-
Antitumor actions of keoxifene and tamoxifen in the JV-nitrosomethylurea-induced rat mammary carcinoma model
-
Gottardis, M. M., and Jordan, V. C. Antitumor actions of keoxifene and tamoxifen in the JV-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res., 47:4020-4024,1987.
-
(1987)
Cancer Res.
, vol.47
, pp. 4020-4024
-
-
Gottardis, M.M.1
Jordan, V.C.2
-
6
-
-
0021038981
-
Antioestrogenic and antitumor activities of a series of non-steroidal antioestrogens
-
Wakeling, A. E., and Valcaccia, B. Antioestrogenic and antitumor activities of a series of non-steroidal antioestrogens. J. Endocrinol., 99:455-464,1983.
-
(1983)
J. Endocrinol.
, vol.99
, pp. 455-464
-
-
Wakeling, A.E.1
Valcaccia, B.2
-
7
-
-
0023902265
-
Inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by tamoxifen without decrease in DNA adduct levels
-
Liehr, J. G., Sirbasku, D. A., Jurka, E., Randerath, K., and Randerath, E. Inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by tamoxifen without decrease in DNA adduct levels. Cancer Res., 48:779-783,1988.
-
(1988)
Cancer Res.
, vol.48
, pp. 779-783
-
-
Liehr, J.G.1
Sirbasku, D.A.2
Jurka, E.3
Randerath, K.4
Randerath, E.5
-
8
-
-
0015915672
-
Anti-oestrogen therapy for breast cancer a trial of tamoxifen at two dose levels
-
Ward, H. W. C. Anti-oestrogen therapy for breast cancer a trial of tamoxifen at two dose levels. Br. Med. J., 1:13-14,1973.
-
(1973)
Br. Med. J.
, vol.1
, pp. 13-14
-
-
Ward, H.W.C.1
-
9
-
-
0017880134
-
Safety of tamoxifen
-
Patterson, J. S., and Baum, M. Safety of tamoxifen. Lancet, 1:105,1978.
-
(1978)
Lancet
, vol.1
, pp. 105
-
-
Patterson, J.S.1
Baum, M.2
-
10
-
-
0021288680
-
32P-postla-beling test for covalent DNA binding of chemicals in viva: application to a variety of aromatic carcinogens and methylating agents
-
Reddy, M. V., Gupta, R. C., Randerath, E., and Randerath, K. 32P-postla-beling test for covalent DNA binding of chemicals in viva: application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis (Lond.), 5:231-243,1984.
-
(1984)
Carcinogenesis (Lond.)
, vol.5
, pp. 231-243
-
-
Reddy, M.V.1
Gupta, R.C.2
Randerath, E.3
Randerath, K.4
-
11
-
-
0022774562
-
Nuclease Pi-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts
-
Reddy, M. V., and Randerath, K. Nuclease Pi-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis (Lond.), 7: 1543-1551,1986.
-
(1986)
Carcinogenesis (Lond.)
, vol.7
, pp. 1543-1551
-
-
Reddy, M.V.1
Randerath, K.2
-
12
-
-
0024417538
-
Mechanism of inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by vitamin C
-
Liehr, J. G., Roy, D., and Gladek, A. Mechanism of inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by vitamin C. Carcinogenesis (Lond.), 10:1983-1988,1989.
-
(1989)
Carcinogenesis (Lond.)
, vol.10
, pp. 1983-1988
-
-
Liehr, J.G.1
Roy, D.2
Gladek, A.3
-
13
-
-
0022972853
-
Metabolic, desmutagenic and anticarcinogenic effects of JV-acetylcysteine
-
Suppl. 1
-
DeFlora, S., Rossi, G. A., and DeFlora, A. Metabolic, desmutagenic and anticarcinogenic effects of JV-acetylcysteine. Respiration 50 (Suppl. 1); 43-49, 1986.
-
(1986)
Respiration
, vol.50
, pp. 43-49
-
-
DeFlora, S.1
Rossi, G.A.2
DeFlora, A.3
-
14
-
-
0020593847
-
Inhibition of estrogen-induced renal carcinoma in Syrian hamsters by vitamin C
-
Liehr, J. G., and Wheeler, W. J. Inhibition of estrogen-induced renal carcinoma in Syrian hamsters by vitamin C. Cancer Res., 43:4638-4642,1983.
-
(1983)
Cancer Res.
, vol.43
, pp. 4638-4642
-
-
Liehr, J.G.1
Wheeler, W.J.2
-
15
-
-
0022472405
-
Inhibition of urethane-induced lung tumors in mice by dietary JV-acetylcysteine
-
DeFlora, S., Astengo, M., Serra, D., and Bennicelli, C. Inhibition of urethane-induced lung tumors in mice by dietary JV-acetylcysteine. Cancer Lett., 32:235-241, 1986.
-
(1986)
Cancer Lett.
, vol.32
, pp. 235-241
-
-
DeFlora, S.1
Astengo, M.2
Serra, D.3
Bennicelli, C.4
-
16
-
-
0024998325
-
Dose-response relationship and low dose extrapolation in chemical carcinogenesis
-
Lutz, W. K. Dose-response relationship and low dose extrapolation in chemical carcinogenesis. Carcinogenesis (Lond.), 11:1243-1247,1990.
-
(1990)
Carcinogenesis (Lond.)
, vol.11
, pp. 1243-1247
-
-
Lutz, W.K.1
-
17
-
-
0024535092
-
Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay
-
Randerath, E., Miller, R. M., Mittal, D., Avitts, T. A., Dunsford, H. A., and Randerath, K. Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay. J. Natl. Cancer Inst., 81: 341-347, 1989.
-
(1989)
J. Natl. Cancer Inst.
, vol.81
, pp. 341-347
-
-
Randerath, E.1
Miller, R.M.2
Mittal, D.3
Avitts, T.A.4
Dunsford, H.A.5
Randerath, K.6
-
18
-
-
0025239673
-
Tamoxifen for breast cancer associated endometrial cancer
-
Gusberg, S. B. Tamoxifen for breast cancer associated endometrial cancer. Cancer (Phila.), 65:1463-1464,1990.
-
(1990)
Cancer (Phila.)
, vol.65
, pp. 1463-1464
-
-
Gusberg, S.B.1
-
19
-
-
0026319776
-
Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver possible involvement of flavin-containing monooxygenases in tamoxifen activation
-
Mani, C., and Kupfer, D. Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver possible involvement of flavin-containing monooxygenases in tamoxifen activation. Cancer Res., 51:6052-6058,1991.
-
(1991)
Cancer Res.
, vol.51
, pp. 6052-6058
-
-
Mani, C.1
Kupfer, D.2
-
20
-
-
26844448080
-
Carcinogenicity of tamoxifen
-
Meschter, C., Kendall, M., Rose, D., Jordan, K., and Williams, G. Carcinogenicity of tamoxifen. Toxicologist, 11: 190,1991.
-
(1991)
Toxicologist
, vol.11
, pp. 190
-
-
Meschter, C.1
Kendall, M.2
Rose, D.3
Jordan, K.4
Williams, G.5
-
21
-
-
0019994312
-
A comparative study of the estrogenic effects of tamoxifen and 17²-estradiol in postmenopausal women
-
Helgason, S., Wilking, N., Carlstrom, K., Damber, M-G., and von Schoultz, B. A comparative study of the estrogenic effects of tamoxifen and 17²-estradiol in postmenopausal women. J. Clin. Endocrinol. Metab., 54: 404-408,1982.
-
(1982)
J. Clin. Endocrinol. Metab.
, vol.54
, pp. 404-408
-
-
Helgason, S.1
Wilking, N.2
Carlstrom, K.3
Damber, M.-G.4
von Schoultz, B.5
|